Skip to main
  1. Stocks
  2. Molina Healthcare
  3. Forecast
MOH

Molina Healthcare (MOH) Stock Forecast & Price Target

Molina Healthcare (MOH) Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 0%
Buy 8%
Hold 83%
Sell 8%
Strong Sell 0%

Bulls say

Molina Healthcare is attractive because its core Medicaid franchise is showing early signs of a margin trough, with FY26 rate outlook raised to 4.5% against 5.5% trend and 2027 rates on 80% of the renewal cohort averaging about 7%, which should narrow the current rate-trend gap. Its earnings power also looks underappreciated: management sees more than $9.50 of adjusted EPS building blocks in 2027, supported by roughly $45 billion of premium revenue, Florida CMS ramp-up, MAPD exit benefits, and operating leverage, before any improvement in legacy MCRs. The stock’s durability is reinforced by a diversified government-sponsored footprint across more than 5 million members, concentrated but defensible state relationships, and upside from conservative work-requirement attrition assumptions, Duals expansion, and conservative new-contract win assumptions.

Bears say

Molina Healthcare is facing a fundamentally fragile earnings bridge because roughly $7.25 per share of the expected move from the 2026 base to 2029 depends on Medicaid rates catching up to trend, even as structural OBBBA cuts and state budget pressure threaten actuarial recovery. The market already prices in much of the near-term recovery at 20.6x the 2027 adjusted EPS estimate, yet the company’s recent Medicaid book has shown elevated medical costs, with trends of 4.5% in 2023, 6.5% in 2024, and 7.5% in 2025, alongside a 6% same-store Medicaid attrition guide for FY2026. In addition, concentration in four major Medicaid states and the large Washington reprocurement risk make contract retention, rate adequacy, and regulatory exposure critical vulnerabilities that justify a cautious outlook.

Molina Healthcare (MOH) has been analyzed by 12 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 8% recommend Buy, 83% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Molina Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Molina Healthcare (MOH) Analyst Forecast & Price Prediction

Get the latest Molina Healthcare (MOH) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Molina Healthcare (MOH)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Molina Healthcare (MOH) Forecast

Analysts have given Molina Healthcare (MOH) a Hold based on their latest research and market trends.

According to 12 analysts, Molina Healthcare (MOH) has a Hold consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $199.42, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $199.42, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Molina Healthcare (MOH)


Molina Healthcare (MOH) Analyst Forecast & Price Prediction

Get the latest Molina Healthcare (MOH) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Molina Healthcare (MOH)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover MOH stock data and trends